E lectroanatomic mapping (EAM) has become an essential tool for substrate-based ablation of scar-related ventricular tachycardia (VT). Structural voltage displays have served to guide ablation lesion sets targeted at transecting scar or encircling border zone tissue. [1] [2] [3] [4] Because the majority of scarrelated VT is hemodynamically untolerated, surrogates in sinus rhythm for sites critical to reentry are desirable and late potentials (LP) in sinus rhythm have become a common ablation target as they exhibit a high sensitivity, albeit with variable specificity. [5] [6] [7] A commonly used strategy for VT ablation is the tagging and targeting of abnormal electrograms with local conduction delay on a voltage-based EAM. However, among all identified LP in a given substrate, it is not known which zone of late activation most commonly provides the substrate for reentry. In addition, LP may be unrelated to any VT circuits and may represent unnecessary ablation targets.
The purpose of the present study is to systematically evaluate the use of functional propagation map displays during sinus rhythm by retrospectively creating isochronal late activation maps (ILAM) to correlate the sites critical to reentry with late activation zones. We hypothesized that the most delayed LPs are not necessarily the most functionally specific for reentry. We prospectively evaluated an ablation strategy targeting regions of slow conduction velocity outside the latest isochrone of ventricular activation during sinus rhythm. nonischemic cardiomyopathy (NICM), and arrhythmogenic right ventricular (RV) cardiomyopathy were included. The diagnosis of ICM was established by history of infarction with Q waves, focal wall motion abnormality, or fixed perfusion defect correlating with coronary stenosis or previous coronary intervention. All ablation procedures were performed under general anesthesia. Epicardial mapping and ablation were left to the discretion of the operator and usually preferred with a history of previously failed endocardial ablation, or ECG or substrate suggestive of epicardial exit was present. The UCLA Medical Center Institutional Review Board approved review of this data.
EAM and Ablation
The approach and strategy for ablation of scar-mediated VT at our center have been previously reported. 8 Noninvasive programmed stimulation was performed under light sedation to assess the morphology of VT and hemodynamic tolerance. Entrainment mapping was performed at the discretion of the operator when VT was hemodynamically tolerated. An isthmus was defined as a site that demonstrated concealed fusion during entrainment with a postpacing interval within 30 ms of the VT cycle length, where the stimulus to QRS interval was equal to EGM-QRS. 9 In cases of unmappable VT, LP sites were tagged and pacemapping was performed and sites with multiple exit sites and pacemapped induction were considered isthmus surrogates. 8 Induction of VT was performed with the ablation catheter positioned at these sites where immediate ablation was attempted on VT initiation, particularly in cases of rapid or hemodynamically unstable VT seen during noninvasive programmed stimulation. High-density electroanatomic maps were created in sinus rhythm using CARTO (Biosense Webster, Diamond Bar, CA) or NAVX (St. Jude Medical, Minneapolis, MN) with standard lowvoltage settings (0.5-1.5 mV). In the cohort of patients mapped using NAVX, field scaling was only applied in cases that resulted in a more spherical ventricular geometry.
Radiofrequency ablation was performed using an open-irrigated catheter (ThermoCool or ThermCool SF, 3.5 mm; Biosense Webster) at 30 to 50 W, temperature limit 45°C at 30-mL flow rate or closedloop irrigated catheter (Chili; Boston Scientific, Natick, MA) at 30 to 50 W, temperature limit 45°C. The temperature limit for epicardial radiofrequency applications was 50°C. Radiofrequency energy was applied for 60 s for each application.
Isochronal Late Activation Mapping
ILAM were constructed retrospectively by manual annotation of all points for a given chamber and surface mapped acquired during sinus rhythm, with the investigator blinded to identified critical ablation sites. Each electrogram was timed at the offset of the local bipolar electrogram deflection, signifying the completion of local activation. The offset was chosen because of a higher degree of reproducibility and less interobserver variability than the onset, maximum dV/dT, or amplitude of a LP, which are more arbitrary and subjective at sites with continuous and fractionated activity. (Figure 1 ). Electrogram deflections with an amplitude lower than the baseline noise or were not reproducibly seen on preceding beats were disregarded with annotation. The timing of all electrograms comprising an ILAM was confirmed by 2 additional observers.
ILAM were displayed with 8 equally distributed isochrones of activation (12.5% of ventricular activation comprised each isochrone). This was chosen because of the difficulty in interpreting maps when settings of >8 were assessed, which obscured distinct isochronal contours. With the CARTO system, the entire window was divided by 8 to determine the duration of each isochronal step and using the NAVX system (St. Jude Medical) the isochronal (local activation time) settings were similarly selected with a color contour setting of 1. In maps where combined epicardial and endocardial mapping was performed, or RV was combined with left ventricular (LV) activation, the largest window that incorporated the timing of both surfaces or chambers was chosen.
The activation within scar was categorized as either a centripetal (from outside into latest isochrone of activation) or a broad wavefront pattern. 10 The number of spatially distinct latest regions of activation was also recorded and compared with the number of VTs induced during the ablation procedure. The offset of the surface QRS complex 
WHAT IS KNOWN
• It is known that sites critical for reentry exhibit delayed and slow conduction that are uncoupled from the myocardium.
• Strategies to homogenize scar by eliminating abnormal electrograms have been shown to be effective during sinus rhythm.
• The functional significance of local potentials with the most delayed activation has not been systematically studied.
WHAT THE STUDY ADDS
• The current data demonstrate that successful ablation sites for ventricular tachycardia are not necessarily correlated with the most delayed late potentials.
• Regions of slow conduction isochrones that centripetally propagate into the latest zone of activation may be more specific targets during sinus rhythm.
relative to the ILAM was measured to analyze the proportion of critical sites with late local activation after the QRS complex.
Characterization of Critical Sites
A site critical for reentry was defined as a site with an electrogram that was mapped within or adjacent to low-voltage regions (<1.5 mV) that exhibited diastolic activity during VT with termination of VT during ablation. Terminations of VT that occurred with ventricular ectopy were excluded to improve specificity. Additional confirmation of sites critical for reentry included isthmus response to entrainment, pacemap match with stimulus-QRS >30 ms, multiple exit site response during pacemapping or a pacemapped induction of VT. 8, 9, 11, 12 At each critical site, the voltage and electrogram timing were recorded during sinus rhythm. Because of potential map localization discrepancies present between sinus rhythm and VT, these measurements were made from the critical electrogram site during sinus rhythm if the catheter was not moved after induction of VT. In cases where mapping during VT was performed, the termination site was annotated on the map immediately on termination in sinus rhythm. To account for changes in voltage and timing from the immediate ablation, the critical site was characterized by averaging the 3 closest neighboring points on the ILAM (consists of mapping points before ablation only). Cases of incessant VT (n=5) were excluded because of ablation necessarily performed before sinus rhythm mapping.
The ventricular activation percentage (VAP) at each critical site was calculated as the timing of the local electrogram offset in sinus rhythm divided by the entire window of activation mapped. The distance between the critical site from the center of the latest isochrone was calculated using the incorporated measurement tool in the respective EAM system and the number of isochrones present within a 1-cm radius of the critical site was counted to estimate the extent of conduction velocity slowing. Isochronal crowding was defined as local deceleration of propagation in a region within scar with bunching of isochrones (>2 isochrones within 1-cm radius).
Prospective Evaluation: Ablation Guided by ILAM
Ten consecutive patients with scar-related VT underwent ablation prospectively guided by ILAM between April 2014 and August 2014. Annotation of all electrograms was performed in real-time, and the ILAM was displayed on a split screen with the voltage map. The ablation strategy targeted regions with concentric isochrones with crowding or bunching outside of the latest isochrone of activation. The second (75%-87.5%) and third latest (62.5%-75%) isochrones were preferentially ablated with circumferential lesion sets until LPs and abnormal electrograms were modified or eliminated. In cases of hemodynamically unstable VT as suggested by noninvasive programmed stimulation during light sedation, induction of VT was performed from the best pacemap site or multiple exit sites outside the latest isochrone of activation with the immediate ablation on induction. In patients with termination of VT, characterization of the critical sites was performed in the same manner as retrospective cases. Consolidation lesions were delivered around the critical sites. Repeat induction was performed after substrate modification outside of the latest isochrone by decremental burst pacing starting at 600 ms down to 300 ms and extrastimulus testing at 2 drive cycles (400 and 500 ms) from ≤3 sites using up to quadruple extrastimuli to 200 ms or ventricular refractoriness.
Statistical Analysis
Categorical variable are expressed as numbers and percentages and were compared using χ 2 or Fisher exact tests. All continuous data are reported as medians with 25% to 75% interquartile percentiles because of the small sample size with non-normal distribution. Wilcoxon rank-sum test (Mann-Whitney) was used to estimate differences between 2 groups and the Kruskal-Wallis test was used to analyze for differences between 3 groups. For statistical comparisons, only 1 critical site for the first VT terminated was compared in patients with multiple critical sites to avoid bias and over-representation from any given patient. A P value of <0.05 was statistically significant.
Results
Between July 2009 and November 2013, 178 patients underwent ablation for scar-related VT. Among these cases, 33 patients with 47 critical sites for VT were identified and met criteria for VT termination seen during the ablation at a critical site that could be retrospectively analyzed.
The cause of cardiomyopathy was ICM in 64%, NICM in 30%, and arrhythmogenic RV cardiomyopathy in 6%. Scar was located in the LV anterior wall in 11 (33%), septum in 12 (36%), inferior wall in 20 (61%), lateral wall in 16 (48%), and 5 (15%) had RV scar. The median ejection fraction was 30% (interquartile range [IQR], 19%-39%) and 48% underwent previous ablation. Ninety-seven percentage had implantable cardioverter defibrillators previously implanted and 85% were taking antiarrhythmic medications (57% amiodarone). Epicardial mapping was performed in 48% (16/33; 2 with epicardial only) and biventricular mapping was performed in 21% (7/33). Patients with NICM underwent epicardial mapping more frequently (75% versus 33%; P=0.021) and biventricular mapping less frequently than patients with ICM (0% versus 33%; P=0.027; Table 1 Table 2 ) When comparing patients who underwent mapping during intrinsic versus paced QRS, there were no statistically significant differences in the duration of the entire window of ventricular activation that comprised the ILAM (160 versus 198 ms; P=0.053) or the post-QRS window of ventricular activation mapped (77 versus 67 ms; P=0.418).
A centripetal pattern of activation with concentric isochrones surrounding the latest isochrone was seen in 91% of patients, whereas a broad wavefront was seen in 9%. There was median of 1 (IQR, 1-2) distinct latest isochronal region in each patient and this did not correlate with the median number of 4 VTs induced per patient (range, 1-7 VTs; P=0.32). Sixty-one percentage of patients had only 1 latest isochronal region, 27% had 2, and 12% had 3 spatially distinct latest isochronal regions. The median VT cycle length of the first VT terminated was 426 ms (IQR, 360-489 ms), and there was no correlation between VT cycle length and the duration of total ventricular activation duration (R 2 =0.063; P=0.08) or with the post-QRS window duration (R 2 =0.001; P=0.8).
Location and Characteristics of Critical Sites
Termination of VT was achieved on the endocardial surface in 68% (32/47) and from the epicardium in 32% (15/47). The substrates with epicardial termination were 5 ICM, 9 NICM, and 1 arrhythmogenic RV cardiomyopathy. Entrainment with concealed fusion was demonstrated in 30% (14/47) of sites. Multiple exit sites was observed at 26% (12/47) and pacemapped induction was seen in 36% (17/47).
In 23 patients who underwent mapping of multiple chambers or surfaces, 90% (26/29) of critical sites for VT were harbored in the chamber or surface with the most delayed activation. For combined epi-endo mapping, 87% (20/23) of critical sites for VT were localized to the latest mapped surface (58% epi and 42% endo). In patients who underwent biventricular mapping (RV and LV), the critical site was located in the ventricle that contained the latest isochrone in 100% of cases (6/6). Figure 2 shows a biventricular map in a patient with inferior myocardial infarction with extensive RV involvement with 2 induced VTs. The termination sites are in the second latest isochrone in the RV, which contains the latest isochrone at the basal inferior wall.
The median voltage at critical sites was 0.47 mV (IQR, 0.17-1.02 ms). There was a trend in critical site location within dense scar in 47% (<0.5 mV) compared with 34% within border zone tissue although this difference was not statistically significant (P=0.4). Nine sites (19%) were in relatively preserved voltage (>1.5 mV) and 6 of these were thought be intramural because of equal epicardial and endocardial timing with delayed termination during ablation.
By ILAM analysis, the median VAP at critical sites was 78%. Only 11% (5/47) of critical sites were localized to the latest isochrone (87.5%-100%) of activation. The second latest isochrone of activation (75%-87.5%) was the most common zone where critical sites were harbored in 36% (17/47; compared with latest isochrone, P=0.01), followed by the third latest (62.5%-75%) isochrones with 28% (13/47) of critical sites (Figure 3 ). Nineteen percentage (9/47) of critical sites were located within the QRS window, whereas 81% (38/47) had an offset after the QRS. Six presumed intramural sites had a median VAP of 50%. Figure 4 shows a voltage map and ILAM in a patient with NICM and ejection fraction of 15% who presented with VT storm. Because of the presence of an LV thrombus, only epicardial mapping and ablation were performed. Two VTs were terminated in the lateral wall of the LV in the second and third latest isochrone of sinus rhythm activation.
The median distance between critical sites and the center of the latest isochrone was 18 mm (IQR, 7-31 mms). Only 15 sites (32%) were within 10 mm. Twenty-four sites (51%) were >2 cm and 10 (21%) >5 cm away from the latest zone of activation on the ILAM. At critical sites, there was a median of 3 isochrones (range, 2-6) isochrones seen within a 1-cm radius (≈38% of the total ventricular activation). Figure 5 shows an example of a patient with NICM with later activation during sinus rhythm in the endocardium than in the epicardium, despite less extensive and less dense scar. The successful termination site occurs at a region with isochronal crowding where 3 isochrones are seen with a 1-cm radius of the critical site.
Potential Influential Factors on the VAP
There was no significant difference in the median VAP of critical sites between patients who were mapped during intrinsic rhythm versus paced (78% versus 79%; P=0.59). There were no differences in the VAP of critical sites when analyzed by anatomic location comparing apical with basal sites and septal with lateral sites. (Figure 6 ). When comparing slow VT (tachycardia cycle length >400 ms) with faster VT (tachycardia cycle length <400 ms), no differences in the VAP of the critical site were observed (79% versus 78%; P=0.9).
The median EGM-QRS during VT at critical sites was 76 ms (IQR, 45-115 ms), which represents 16% of the tachycardia cycle length. When analyzing sites located in the midisthmus (30%-70%) versus distal isthmus (<30% tachycardia cycle length), the VAP was later at mid-isthmus compared with distal sites (81% versus 69%; P=0.06). Among 8 critical sites located in the mid-isthmus, 7 (88%) were found within the 62.5 to 87.5% isochrones ( Figure 6 ).
Prospective Cases
Ten cases (ICM n=5) were performed prospectively using ILAM to guide ablation. Patient characteristics are shown in Table 1 . The scar location was LV anterior in 2 (20%), LV septum in 3 (30%), LV inferior in 6 (60%), LV lateral in 4 (40%), and 1 in the RV (10%). Termination of VT during ablation (median, 4.5 s) was achieved in 6 of these cases, where 4 were hemodynamically unstable.
Among these 6 VT terminations, 5 achieved termination within the first 2 radiofrequency applications. Three patients (NICM=2; Chagas=1) underwent combined epicardialendocardial mapping. The critical sites in these patients were located on the endocardium, and the endocardial ILAM window was more delayed than the epicardial window in all 3. In 3 cases, ILAM were created using multiple wavefronts of activation (RV and LV) and none of the critical sites were in the latest isochrones of activation (Figure 7) .
The median VAP at critical sites was 78%. Procedural characteristics of patients with VT termination are shown in Table 2 . Only one of these termination sites occurred within the latest isochrone of activation (VAP, 89%), and this had the latest termination of 42 s. A passive bystander was demonstrated in the latest isochrone in a patient with inferior myocardial infarction (Figure 8 ). There were 3.5 isochrones within 1 cm of the successful site, and the distance from the critical site from the latest isochrone was 13 mm (IQR, 10-16 mm).
Homogenization targeting the regions outside the latest isochrone in areas of isochronal crowding was performed in all cases. Complete noninducibility was achieved in 40%, elimination of the clinical VT in 50%, and 1 patient was not tested post ablation. At 6±1 months of follow-up, 80% of the patients remained free of VT recurrence, with 50% off antiarrhythmic therapy.
Discussion
The major findings of the present study are:
1. Sites critical for reentry are frequently identified outside the latest isochrone of ventricular activation during sinus rhythm but are commonly localized to the surface or chamber mapped with the most delayed activation. 2. Regions of conduction slowing with isochronal crowding that propagate into the latest zone of activation can be identified and targeted with functional mapping displays to eliminate VT.
Because most LPs mapped are merely tagged on scar voltage maps in clinical practice, this is the first analysis, to our knowledge, to correlate sites critical for scar-related VT with isochronal activation patterns during sinus rhythm in humans. 13 It has been previously demonstrated that the targeting of earlier LPs frequently results in elimination of delayed activation downstream in a channel, 14, 15 but the functional significance of these upstream regions during VT has not been systematically evaluated. An understanding of whether a specific late activation zone identified during sinus rhythm has a higher yield for VT elimination may have an immediate impact on substrate ablation strategies. Because the advent of EAM systems, ablation of VT has evolved from anatomically based strategies to targeting functional regions of local conduction slowing within scar. Guided by pacemapping, linear lesions sets across dense scar and at border zones have been shown to reduce VT recurrence. 1-4,12 The relationship of critical sites to voltage-based scar anatomy has been previously reported. Whereas Hsia et al 16 found that 84% of entrance and mid-isthmus sites were localized to dense scar, Verma et al 17 reported that 68% of critical sites were localized to border zone in patients with ICM. Arya et al 18 described that adjustment of voltage thresholds to more dense settings exposed potential isthmus regions with relatively preserved conducting channels. However, Mountantonakis et al 19 demonstrated that channels exposed by threshold adjustments were poorly predictive of isthmuses, suggesting that the macroscopic identification of a channel by structure alone is not always feasible. Jamil-Copley et al 20 more recently showed the potential use of ripple mapping, which demonstrates both voltage and propagation channels into scar in a single dynamic display. This technology has the advantage of displaying complex or continuous fractionated local electrograms as time-dependent propagation, rather than choosing a single annotation for timing.
Because reentrant VT requires fixed or functional localized conduction slowing, Brunckhorst et al 21 demonstrated with multiple wavefront mapping that regions with fixed and functional conduction delay may be equally critical for VT maintenance. Jaïs et al 22 further advanced the concept that abnormal multicomponent electrograms within the QRS during sinus rhythm can be functionally delayed with extrastimuli because of local uncoupling. In the present study, we demonstrate that the majority of sites critical to reentry exhibit a certain extent of fixed conduction slowing during sinus rhythm with isochronal crowding and electrogram components outside of the QRS, although intra-QRS LPs comprised 19% of the cohort. For this reason, ILAM analysis incorporates the entire ventricular window of activation, rather than the post-QRS window alone.
The present findings suggest that an adjunctive EAM display can complement current ablation strategies based on a functional prioritization of activation within scar. Mechanistically, it seems that the latest LPs may not be the most specific and, therefore, may not require targeted ablation. Zones with the most delayed activation during sinus rhythm may represent regions that are extraneous or proximal to the circuit during VT (entrance, inner loop sites) or bystander sites. Within a given isochrone, the thinnest portion represents regions with the slowest conduction velocity and, therefore, localized areas of isochronal crowding or bunching signify the greatest extent of fixed conduction slowing during sinus rhythm.
Assadi et al 13 first examined the relationship of reentrant isthmus sites with isochronal sinus activation mapping in a postinfarct animal model. In >50% of cases, the critical sites were at least 24 mm away from the latest isochrone of activation. These observations were limited to epicardial mapping and were not extended to humans. The present analysis is consistent with these findings, where critical sites are frequently remote from the latest LPs. Importantly, the relationship between regions of slow conduction during sinus rhythm is not expected to mirror regions of slow conduction during VT as functional lines of block develop during a different reentrant wavefront. The pattern and direction of the reentrant wavefront are critically dependent on local refractory periods, which is not incorporated in the current ILAM analysis.
The centripetal pattern of activation of scar seen with ILAM, from the periphery to the center, has mechanistic and clinical implications. Haqqani et al 10 described a similar propagation in arrhythmogenic RV cardiomyopathy patients with epicardial scar and hypothesized independent layered activation in the endocardium and epicardial. The present findings suggest that this pattern of scar activation is observed in the majority of patients. The centripetal activation of channels also supports that a circumferential lesion set has the potential to electrically isolate the center of late activation within concentric isochrones.
In the present study, the number of regions within scar with the most delayed activation did not correlate with the number of VTs induced. This is consistent with shared isthmuses that may support different VT morphologies and that the targeting of 1 zone of late activation may simultaneously eliminate nontargeted VTs. 6 In addition, there was no relationship between the VT cycle length and indices of conduction slowing derived from ILAM (ie, total ventricular activation time, post-QRS window, or isochrone percentage). This is consistent with regions with less evident slow conduction during sinus rhythm developing a greater degree of functional slowing along the arc of unidirectional block during VT.
Limitations
The generalizability of this study is limited by the relatively small sample size of patients. Importantly, ILAM displays do not actually represent activation into each electrogram site, but rather the completion of activation, as we specifically chose the offset of the last deflection back to the baseline to optimize reproducibility and minimize subjectivity. This is largely because of the lack of standardized criteria for distinguishing near-field potentials from far-field activity. Interobserver variability is likely to increase when assigning the onset, maximum, or highest frequency deflection of a continuous or fractionated signal.
Studies evaluating LP in sinus rhythm all represent fixed conduction slowing with 1 directional wavefront of activation. In addition, the anatomic location of scar influences the relative timing of the near-and far-field components of a local electrogram. The wide distribution of VAP at critical sites across septal and lateral regions and apical and basal regions observed in this cohort suggests that in the presence of dense scar, the latest isochrones activated through centripetal propagation into scar with concentric isochrones may not significantly vary with the wavefront of activation.
The appearance of ILAM is sensitive to the latest electrogram identified. The value and relative timing of a site during map creation cannot be assessed until the entire ventricle is mapped. The failure to map a later activation site for a given ILAM does not necessarily mean that a later site of activation is not present. Therefore, in the cases where the critical sites were found in the latest isochrone, later sites of activation not identified on the same surface or present transmurally are possible. Isochronal thickness was not measured because of inaccuracies that are present from interpolation.
Termination of VT can theoretically be achieved at different components of the reentrant circuit. It is not conclusive from the present data that termination cannot be achieved in the latest isochrone, but rather that termination is not commonly observed in the regions of most delayed activation in this study. Entrainment mapping was not performed in all cases, but in the real-world, clean termination of VT remains an accepted proof of a site critical to the maintenance of reentry when diastolic activity is recorded. In patients with multiple VTs, the exact localization of the critical sites for all morphologies could not be ascertained because of the fact that the majority of VTs are untolerated and variably inducible during ablation.
Conclusions
LPs in the latest isochrone of activation during sinus rhythm are infrequently correlated with successful ablation sites for VT. The latest LPs may be bystander sites during reentry. Slow conduction regions with isochronal crowding propagating into the latest zone of activation may be a promising ablation target for substrate modification. ILAM during sinus rhythm may provide complementary and targeted functional information beyond structural voltage displays for scarrelated VT and represents a novel strategy for substrate-based VT ablation.
